Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis

N Engl J Med. 2024 May 30;390(20):1939. doi: 10.1056/NEJMc2404353.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Eosinophils / drug effects
  • Granulomatosis with Polyangiitis* / drug therapy
  • Granulomatosis with Polyangiitis* / immunology
  • Humans

Substances

  • Antibodies, Monoclonal, Humanized
  • benralizumab
  • mepolizumab